Avista Public Acquisition Corp. II AHPA
6.13 0.00 (+0.00%)
At closeNov 2, 2022, 12:00 AM EDT
5.83 Day range 7.20
5.83 52-week range 10.50
News
businesswire.com OmniAb Announces Completion of Spin-Off and Business Combination EMERYVILLE, Calif.
businesswire.com Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma SAN DIEGO--(BUSINESS WIRE)--Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab)
businesswire.com OmniAb Business Combination Approved by APAC Shareholders SAN DIEGO--(BUSINESS WIRE)--OmniAb Business Combination Approved by APAC Shareholders
businesswire.com Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off EMERYVILLE, Calif.--(BUSINESS WIRE)-- #earnings--Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
businesswire.com Ligand Reports Second Quarter 2022 Financial Results EMERYVILLE, Calif.--(BUSINESS WIRE)-- #earnings--Ligand Reports Second Quarter 2022 Financial Resultsbenzinga.com Stocks That Made New 52-Week Highs Friday, October 26th
benzinga.com Stocks Which Set New 52-Week High Yesterday, September 11th
